Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Keratosis, Actinic 1Carcinoma, Squamous Cell 1

Interventions

3-ingenyl angelate 33Imiquimod 18Aminolevulinic Acid 16Gels 10Diclofenac 10Photochemotherapy 7methyl 5-aminolevulinate 6Fluorouracil 6Solutions 5LEO 43204 5BF-200 ALA 5tirbanibulin 4Ointments 4Cryotherapy 3SR-T100 2potassium dobesilate 1green tea extract polyphenone E 1beta-solamarine 1afamelanotide 1Therapies, Investigational 1Therapeutics 1Petrolatum 1Excipients 1Drugs, Generic 1Cryosurgery 1Control Groups 1AVX001 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Keratosis, Actinic × Excipients × Clear all
NCT02844777 2023-01-12

Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

Vidac Pharma

Phase 2 Completed
93 enrolled 13 charts
DermatologicOther neoplasm

Carcinoma, Squamous Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡